Table 4 Performances of different quantitative variables in distinguishing malignant lesions from benign ones
Variable (Cut-off Point) | AUC (95% Confidence Interval) | Sensitivity (%) | Specificity (%) | NPV (%) | PPV (%) | Accuracy (%) |
|---|---|---|---|---|---|---|
Signal intensity of T2 | – | 100 | 70.2 | 100 | 45.7 | 76.2 |
Central Necrosis | – | 47.6 | 95.2 | 87.9 | 71.4 | 85.7 |
T2 Map (82.5) | 0.974 (0.930–0.988) | 95 | 91.2 | 98.4 | 76.0 | 92.0 |
T2 Scaled Ratio (0.32) | 0.952 (0.914–0.983) | 100 | 83.3 | 100 | 58.8 | 86.5 |
Tumor Myometrium Contrast Ratio on T2 (0.31) | 0.930 (0.851–0.966) | 100 | 70.7 | 100 | 44.2 | 76.2 |
Tumor Psoas Contrast Ratio on T2 (1.58) | 0.902 (0.787–0.974) | 95.2 | 82.1 | 98.6 | 57.1 | 84.8 |
Tumor Myometrium Contrast Enhanced Ratio (0.23) | 0.887 (0.835–0.968) | 100 | 74.4 | 100 | 47.5 | 79.2 |
Tumor Psoas Contrast Enhanced Ratio (1.23) | 0.840 (0.742–0.900) | 81 | 73.8 | 93.9 | 43.6 | 75.2 |